Clinical Trial Update: Treatment of Refractory Urinary Retention Secondary to Benign Prostatic Hyperplasia (BPH) With Dual Five Alpha Reductase Inhibition Combined With an Alpha Blocker [NA]

View source ↗

Summary

This completed trial investigated combining dual 5-alpha reductase inhibition with an alpha blocker to treat refractory urinary retention due to benign prostati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Urinary Retention

Snippet

Sponsor: Franklin D. Gaylis, MD Inc. | Conditions: Urinary Retention, Benign Prostatic Hyperplasia | NA | Status: COMPLETED